Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Open Access
- 7 March 2013
- journal article
- review article
- Published by Hindawi Limited in Journal of Drug Delivery
- Vol. 2013, 1-32
- https://doi.org/10.1155/2013/705265
Abstract
Liposomes are delivery systems that have been used to formulate a vast variety of therapeutic and imaging agents for the past several decades. They have significant advantages over their free forms in terms of pharmacokinetics, sensitivity for cancer diagnosis and therapeutic efficacy. The multifactorial nature of cancer and the complex physiology of the tumor microenvironment require the development of multifunctional nanocarriers. Multifunctional liposomal nanocarriers should combine long blood circulation to improve pharmacokinetics of the loaded agent and selective distribution to the tumor lesion relative to healthy tissues, remote-controlled or tumor stimuli-sensitive extravasation from blood at the tumor’s vicinity, internalization motifs to move from tumor bounds and/or tumor intercellular space to the cytoplasm of cancer cells for effective tumor cell killing. This review will focus on current strategies used for cancer detection and therapy using liposomes with special attention to combination therapies.Keywords
Funding Information
- National Institutes of Health (U54CA151881)
This publication has 187 references indexed in Scilit:
- Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imagingBiomaterials, 2013
- Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug deliveryBiomaterials, 2012
- Targeting of Liposomes via PSGL1 for Enhanced Tumor AccumulationPharmaceutical Research, 2012
- Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesEMBO Molecular Medicine, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Targeted delivery of doxorubicin using stealth liposomes modified with transferrinInternational Journal of Pharmaceutics, 2009
- The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and menCancer Chemotherapy and Pharmacology, 2006